Preliminary research on the p53 gene rearrangements in the evolution of chronic myelogenous leukemia to blast crisis

Chen Jing-chun , Liu Shu-mao , Fei Hong-bao , Gong Wei-long

Current Medical Science ›› 1994, Vol. 14 ›› Issue (4) : 204 -208.

PDF
Current Medical Science ›› 1994, Vol. 14 ›› Issue (4) : 204 -208. DOI: 10.1007/BF02897668
Article

Preliminary research on the p53 gene rearrangements in the evolution of chronic myelogenous leukemia to blast crisis

Author information +
History +
PDF

Abstract

DNA from 36 patients with chronic myelogenous leukemia (CML) at various clinical stages and 6 cases of acute leukemia was investigated for alterations of the p53 gene by Southern blot analysis. Rearrangements of the p53 gene were seen in 3 of 12 (25.00%) cases of blast crisis and accelerated phase (AP) of CML and in only one of 18 chronic phrase (CP), just as has been reported previously. Meanwhile, by restriction fragment length polymorphism (RFLP) analysis the Bgl II site polymorphism in the p53 gene was also found. The frequency in Chinese people detected here was 0. 392, which was strikingly higher than that in some other countries (P< 0. 001). These results suggested that the alterations of the p53 gene, for example, p53 rearrangements, were probably responsible for the progression of BC in some CML patients, and that the frequency of Bgl II polymorphism in the p53 gene might be related to the population distribution.

Keywords

chronic myelogenous leukemia / blast crisis / p53 gene / Southern blot analysis / restriction fragment length polymorphism

Cite this article

Download citation ▾
Chen Jing-chun, Liu Shu-mao, Fei Hong-bao, Gong Wei-long. Preliminary research on the p53 gene rearrangements in the evolution of chronic myelogenous leukemia to blast crisis. Current Medical Science, 1994, 14(4): 204-208 DOI:10.1007/BF02897668

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

AhujaH, Bar-EliM, ArlinZ, et al. . The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. J Clin Invest, 1991, 87: 2042-2042

[2]

KelmanZ, ProkocimerM, PellerS, et al. . Rearrangements of the p53 gene in Philadelphia chromosome positive chronic myelocytic leukemia. Blood, 1989, 74: 2318-2318

[3]

HarlowE, WilliamsmN M, RalstonR, et al. . Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Mol Cell Biol, 1985, 5: 1601-1601

[4]

ManiatisT, FritschE F, SambrookJ. Molecular Cloning, 19821st edNew York, Cold Spring Harbor Laboratory Press

[5]

FeinbergAP, VogelsteinB. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem, 1984, 137: 266-266

[6]

MashalR, ShtalridM, TalpazM, et al. . Rearrangements and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia. Blood, 1990, 75: 180-180

[7]

LiuE, HjelleB, BishopJ M. Transforming genes in chronic myelogenous leukemia. Proc Natl Acad Sci USA, 1988, 85: 1952-1952

[8]

McCarthyD M, GoldmanJ M, RasoolF V, et al. . Genomic alterations involving the c-myc proto oncogene during the evolution of case of chronic granulocytic leukemia. Lancet, 1984, 11: 1362-1362

[9]

MiwaH, KttaK, SayaH, et al. . Structural alterations of the p53 gene in human leukemias. Leukemia Res, 1992, 16: 1105-1105

[10]

BuchmanV L, ChumakovP M. Ninkina N N, et al. . A variation of the protein-coding region of the human p53 gene. Gene, 1988, 70: 245-245

AI Summary AI Mindmap
PDF

72

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/